Article Details
Retrieved on: 2021-07-14 15:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The two companies agree to jointly explore the development of APG-2575 with the anti-CD20 monoclonal antibody HALPRYZA® (rituximab biosimilar ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here